ICD-10 Coding for Positive Antinuclear Antibody(I73.0U, M35.9U, R76.0)
Learn about ICD-10 coding for positive antinuclear antibody, including R76.0 and R76.8, documentation requirements, and clinical validation.
Complete code families applicable to Positive Antinuclear Antibody
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R76.0 | Raised antibody titer | Use when ANA titer is elevated but no specific pattern is documented. |
|
| R76.8 | Other specified abnormal immunological findings | Use when specific ANA patterns are documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPositive Antinuclear Antibody
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Positive Antinuclear Antibody.
Omitting ANA pattern documentation
Impact
Clinical: May lead to misdiagnosis., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation
Ensure lab reports include pattern details., Train staff on documentation standards.
Coding R76.0 without a titer value
Impact
Reimbursement: May lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure titer value is documented before coding.
ANA testing without clinical indication
Impact
Testing without documented clinical suspicion can lead to audits.
Mitigation
Ensure clinical symptoms are documented before testing.